The WuXi AppTec Research Service Division (RSD) supports clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, RSD works collaboratively to rapidly advance programs from target through to preclinical selection and beyond.
RSD’s discovery platform encompasses biology, chemistry, structural biology, biophysics and ADME/PK, in addition to the capabilities of newly acquired HD Biosciences (HDB), and is trusted by over 1,900 international clients, ranging from pharma and biotech to academia and non-profit institutions.
This integration of capabilities allows a collaborative environment, enabling enhanced efficiency and productivity. WuXi RSD strives to continually develop and enhance its scientific capabilities and technology to maintain its industry leading position. We aim to provide outstanding services to our existing partners and to the broader discovery community!
Over 4,000 chemists,
1,000 biologists and 400 analytical scientists
170 supported programs progressed into clinical development
Total Global Employees
Area of Laboratory (sq.m.)
Global Site and Office
RSD Integrated Platform
Target validation, CRISPR
Arrays, libraries, DELs
Unique scaffolds, building blocks
DNA Encoded Libraries
Customized screening decks
In vitro efficacy & MoA
In vivo efficacy
In vitro SAR support
In vivo target engagement
In vivo pharmacology
Optimization of hits and leads
hERG, other safety profiling services
Additional in vitro and in vivo characterization
Scale up of candidates for preclinical studies
Synthetic optimization of candidates
Metabolic and impurity identification synthesis
Clinical l - lll
CAP-certified FACS, pathology, molecular testing
Partnering with RSD
Track record of delivery, leadership and scientific excellence
A comprehensive and integrated portfolio of discovery services
>5,000 scientists across chemistry, analytical and biology
Cost-effective, scalable solutions delivering quality data
Global footprint with operations in North America, Asia and Europe
Established IP protection policies and procedures. Seamless pathway from our discovery platforms to our development platforms
Delivering our partners preclinical discoveries through world class capabilities,
directed by teams with a reputation for collaboration and scientific excellence.
Research Service Division
Leadership and Excellence in Contract Research
RSD enables anyone or any company to discover and develop new drugs and products with a benefit to patients.
RSD services deliver extraordinary performance and an unwavering focus on customer satisfaction.